The Experts in Animal Health

print version

Brakke Consulting’s
Animal Health News & Notes for January 3, 2014
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
2014 Industry Overview
Investor Seminar
OTC Channel
other news
Aquapharm Bio-Discovery
Biogénesis Bagó
Kane Biotech
Vets Plus
INVESTOR SEMINAR: Understanding the Animal Health Industry (Investment Opportunities and Strategies)

Brakke Consulting, Inc. will present a one-day seminar for investors entitled, “Understanding the Animal Health Industry (Investment Opportunities and Strategies)” on February 11, 2014 at the Newark Liberty International Airport Marriott in Newark, New Jersey.

The seminar will include the following topics:
– Industry Overview
– Size and trends of the animal health industry markets
– Size and trends of the US OTC market for pet products
– Segment breakdown of US pet and OTC markets
– Industry ownership trends
– Industry transaction history over the past decade
– Major influencers on the financial health of the industry
– A review of potential investment opportunities and strategies

The deadline for registering is Wednesday, February 5. To register, please call Brakke Consulting at (972) 243-4033. For more information email Jane Morgan,

In the year-end news roundup, the following items were incorrectly reported:
– Elanco, not Zoetis, acquired the Titanium and Master Guard vaccine brands from Agrilabs
– Merck received a positive opinion recommending EU marketing authorization for Bravecto, not the marketing authorization
> Ceva Sante Animale confirmed that the company is seeking new financial partners as part of an upcoming leveraged buy-out. (Animal Pharm)
> Norbrook Laboratories, Ltd. announced that the FDA has re-instated in full its prior approval of the sale and use of Norbrook’s new Enroflox100 (enrofloxacin) in cattle and non-lactating dairy heifers less than 20 months of age. (company press release)
> Neogen Corporation announced that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. Neogen has shared the Prozap insecticide trademark with Chem-Tech for a number of years. Chem-Tech’s revenues for the most recent 12 months exceeded $14 million. Financial terms were not disclosed. (company press release)
> Harrisvaccines announced it is seeking a conditional USDA approval to more widely market its “iPED” Porcine Epidemic Diarrhea virus, or PEDv, vaccine. The vaccine is currently available through a veterinarian prescription basis only. (AVMA SmartBrief – Reuters) 
> Vets Plus, Inc. and the University of Minnesota announced the renewal of a consultancy agreement for veterinary supplements. The University’s College of Pharmacy has provided the animal nutrition company with consultation on formulations for new products since 2009; the agreement renews the contract through 2015. (company press release) 
> Kane Biotech announced an option agreement with an unnamed global healthcare company for the use of its antibiofilm and antimicrobial oral and wound care technologies in the animal health market. Full details of the agreement were not disclosed. (Animal Pharm)
> Lallemand Animal Nutrition announced the acquisition of the marine biotechnology business and assets of Scotland-based Aquapharm Bio-Discovery. The assets include a library of marine microbes with potential as feed additives for livestock production and aquaculture. Financial terms were not disclosed. (Animal Pharm) 
> SOUTH AMERICA  Biogénesis Bagó announced the South American launch of FLOK, an injectable formulation of doramectin for control of parasites in cattle and sheep. FLOK incorporates proprietary technology called MABS, which allows the product to offer higher efficiency in controlling gastrointestinal parasites, Horn fly, myasis and ticks. (Animal Pharm)

Brakke Consulting will present the 2014 US Animal Health Industry Overview twice this winter – once at the North American Veterinary Conference in Orlando, Florida and once at the Western Veterinary Conference in Las Vegas, Nevada. These dates are:
• NAVC: Monday, January 20, 2:00 – 4:00 pm, Gaylord Palms.
• WVC: Tuesday, February 18, 2:00 – 4:00 pm, Four Seasons.

Registration for the Industry Overview at the NAVC and WVC is now open.  Seating is very limited this year, so register early!
To register, go to  and scroll down to the “What’s New” box. The price is $385 per person for online registration; late registration is $425.

> CHINA – AVIAN INFLUENZA  The southwest China province of Guizhou has reported an outbreak of H5N1 in poultry on a farm where 8,500 chickens died. The National Avian Influenza Reference Laboratory confirmed the epidemic was H5N1 avian influenza after testing samples collected at the farm. A total of 23,067 chickens have been culled and safely disposed of to prevent the disease from spreading. (

Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution. If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at

Much of the news this week has been generated by some of the medium and smaller sized companies serving the industry. Several of these firms are companies to watch in 2014 and beyond for their strategic approaches and entrepreneurial attitudes towards the animal health business. A number of them have generated double digit year-over-year revenue growth, exceeding their peer group of companies and the industry.
As we develop our 2014 Animal Health Industry Overview it becomes clear that some of the growth occurring in the industry is not from the larger companies who operate in some of the leading product areas. Instead, a broad base of smaller and medium sized companies operating in non-traditional product areas and various services companies are driving a reasonable amount of the industry growth. If you’d like Brakke Consulting’s views on where some of the leading growth areas will be in 2014 and beyond, we encourage you to register for one of our Industry Overviews to be held in January and February in various locations.

Happy New Year! Have a great weekend as we close out the Holiday Season!
Ron Brakke
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA

en_USEnglish (United States)